Estimates of overdiagnosis of invasive breast cancer associated with screening mammography

Cancer Causes and Control

Volumn 21, Issue 2, 2010, Pages 275-282

  Morrell, Stephen ^a   Barratt, Alexandra ^a   Irwig, Les ^a   Howard, Kirsten ^a   Biesheuvel, Corné ^a,b   Armstrong, Bruce ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Breast cancer incidence; Mammography screening; Overdiagnosis

Indexed keywords

ADULT; AGE DETERMINATION; AGED; ARTICLE; AUSTRALIA; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC ERROR; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MATHEMATICAL ANALYSIS; NULLIPARA; OBESITY; OVERDIAGNOSIS; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DIAGNOSTIC ERRORS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM INVASIVENESS; NEW SOUTH WALES; OBESITY; PARITY; PREGNANCY; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 77950690422     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9459-z     Document Type: Article

References (41)

1. 1. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA (2005) Global trends in breast cancer incidence and mortality 1973-1997. Int J Epi 34:405-412 (Pubitemid 40645331)
2. Australian Institute of Health and Welfare (2003) BreastScreen Australia Monitoring Reports 1998-99, 1999-2000 and 2000-2001. Cancer series numbers 25 and 26; AIHW Cat.Nos. CAN 20 and CAN 21, Canberra, AIHW
3. 3. Ernster V, Barclay J, Kerlikowske K, Grady D, Henderson C (1996) Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275(12):913-918 (Pubitemid 26095381)
4. Barratt A, Irwig L, Glasziou P, Cumming R, Raffle A, Hicks N et al (1999) Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidencebased medicine working group. JAMA 281(21):2029-2034
5. Gilbert Welch H (2009) Overdiagnosis and mammography screening. BMJ 339:b1425. doi:10.1136/bmj.b1425 (Published 9 July 2009)
6. 6. Russo J, Moral R, Balogh GA, Mailo D, Russo IH (2005) The protective role of pregnancy in breast cancer. Breast Cancer Res 7(3):131-142 (Pubitemid 40704134)
7. 7. Mastorakos G, Sakkas EG, Xydakis AM, Creatsas G (2006) Pitfalls of the WHIS: women's health initiative. Ann N Y Acad Sci 1092:331-340 (Pubitemid 47092350)
8. 8. Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L (2007) Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol 8(12):1129-1138 (Pubitemid 350182969)
9. 9. Olsen AH, Jensen A, Njor SH, Villadsen E, Schwartz W, Vejborg I et al (2003) Breast cancer incidence after the start of mammography screening in Denmark, Br J Cancer 88(3):362-365 (Pubitemid 36308145)
10. Zahl PH, Strand BH, Maehlen J (2004) Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 328(7445):921-924
11. 11. Zahl P, Jorgensen KJ, Maehlen J (2008) Biases in estimates of overdetection due to mammography screening. Lancet Oncology 9:199-201 (Pubitemid 351722941)
12. 12. Boer R, Warmerdam P, De Koning HJ, van Oortmarssen G (1994) Extra incidence caused by mammographic screening. Lancet 343:979 (Pubitemid 24117251)
13. 13. MacLennan AH, MacLennan A, Wilson D (1993) The prevalence of oestrogen replacement therapy in South Australia. Maturitas 16:175-183 (Pubitemid 23151274)
14. 14. MacLennan AH, Wilson DH, Taylor AW (2002) Hormone replacement therapy use over a decade in an Australian population. Climacteric 5(4):351-356 (Pubitemid 36143354)
15. Australian Institute of Health and Welfare (AIHW) Analysis of the 1980, 1983 and 1989 risk factor prevalence surveys, 1995 National Nutrition Survey and 1999-2000 Australian diabetes, obesity and lifestyle (AusDiab) study. Accessed from http://www.aihw.gov.au/dataonline/riskfactors/index.cfm
16. Australian Bureau of Statistics (2005) Births, Australia, 2005. 2006; cat. no.3301.0. ABS, Canberra
17. 17. Lahmann PH, Hoffmann K, Allen N, Van Gils CH, Hhaw K-T, Tehard B, Berrineo F et al (2004) Body size and breast cancer risk: findings from, the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 111:762-771 (Pubitemid 39062901)
18. Feigelson HS, Jonas CR, Teras LR, Thun MJ, Calle EE (2004) Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 13:220-224
19. 19. Ann J, Schatzkin A, Lacey JV Jr, Albanes D, Ballard-Barbash R, Adams KF, Kipnis V, Traci Mouw T, Hollenbeck AR, Leitzmann MF (2007) Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med 167(19):2091-2100 (Pubitemid 350036709)
20. 20. Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, Yaffe M., Minkin S (2006) Body size, mammographie density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15(11): 2086-2092 (Pubitemid 44877030)
21. 21. Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, Lopez AM, Manson J, Margolis KL, Muti PC, Stefanick ML, McTiernan A (2002) Obesity, body size, and risk of postmenopausal breast cancer: The women's health initiative (United States). Cancer Causes Control 13(8):741-751 (Pubitemid 35204050)
22. 22. Michels KB, Terry KL, Willett WC (2006) Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med 166:2395-2402 (Pubitemid 44833368)
23. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD (2002) Postmenopausal hormone replacement therapy: scientific review. JAMA 288(7):872-881
24. 24. Brinton LA, Hoover R, Fraumeni JF Jr ( 1983) Reproductive factors in the aetiology of breast cancer. Br J Cancer 47(6):757-762 (Pubitemid 13053504)
25. Estoesta JV, Gao K, Taylor RJ, Ho C, Brassil AE (2004) BreastScreen New South Wales Statistical Report: 1999-2002. BreastScreen NSW, Sydney
26. Day N (1987) Cumulative rate and cumulative risk. In: Muir C, Waterhouse J, Mack T et al (eds) Cancer incidence in five continents, Vol 5. [Chapter 10]. International Agency for Research on Cancer, Lyon (IARC Sci Publ No 88.)
27. SAS Institute Inc. (1999) SAS: statistical software. Version 8.02. SAS Institute, Cary
28. Duffy SW, Lynge E, Jonsson H, Ayyaz S, Olsen AH (2008) Complexities in the estimation of overdiagnosis in breast cancer screening. Br J Cancer 99(7): 1176-1178
29. Canfell K, Banks E, Moa AM, Beral V (2008) Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust 188(1,1):641-644
30. van Oortmarssen GJ, Habbema JD, van der Mass PH, de Koning HJ, Collette HJ, Verbeek AL, Geerts AT, Lubbe KT (1990) A model for breast cancer screening. Cancer 66(7): 1601-1612
31. Boer R, de Koning HJ, van Oortmarssen GJ, van der Maas PJ (1995) In search of the best upper age limit for breast cancer screening. Eur J Cancer 31.(12):2040-2043
32. 32. Zackrisson S, Andersson I, Janzon L, Manjer J, Game JP (2006) Rate of over-diagnosis of breast cancer 1.5 years after end of Malmo mammographic screening trial: follow-up study. BMJ 332(7543):689-692 (Pubitemid 44365683)
33. Gotzsche PC, Nielsen M (2006) Screening for breast cancer with mammography [Systematic Review] Cochrane Database of systematic reviews
34. 34. Chiu C, Morrell S, Page A, Rickard M, Brassil A, Taylor R (2006) Population-based mammography screening and breast cancer incidence in New South Wales, Australia. Cancer Causes Control 17(2): 153-160 (Pubitemid 43121764)
35. 35. Irwig L, Houssami N, Armstrong B, Glasziou P (2006) Evaluating new screening tests for breast cancer. BMJ 332:678-679 (Pubitemid 44365679)
36. 36. Jonsson HR, Johansson R, Lenner P (2005) Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer 117:842-847 (Pubitemid 41598838)
37. Jorgensen KJ, Gotzsche PC (2009) Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 339:b2587. doi:10.1136/bmj, b2587
38. 38. Mathieu E, Barratt A, Davey H, McGeechan K, Howard K, Houssami. N (2007) Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women [see comment]. Arch Intern Med 167:2039-2046 (Pubitemid 350036702)
39. 39. Glas AM, Floore A, Delahaye LJ, Witteveen AT, Pover RC, Bakx N, Lahti-Domenici JS, Bruinsma TJ, Warmoes MO, Bernards R, Wessels LF, Van't Veer LJ (2006) Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 7:278 (Pubitemid 44773844)
40. van de Vijver MJ, He YD, Van't Veer LJ, Dai. H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347(25): 1999-2009
41. Pharoah PD, Antoniou AC, Easton DF, Ponder BA (2008) Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 358(26):2796-2803